Efthymia Vargiami1, Stella Stabouli2, Christina Sidira1, Maria Kyriazi1, Athanasia Anastasiou3, Athanasios Notopoulos4, Dimitrios Zafeiriou1. 1. First Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Hippokratio Hospital, 49 Konstantinoupoleos Str, 54642, Thessaloniki, Greece. 2. First Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Hippokratio Hospital, 49 Konstantinoupoleos Str, 54642, Thessaloniki, Greece. sstaboul@auth.gr. 3. Department of Radiology, Hippokratio Hospital, Thessaloniki, Greece. 4. Department of Nuclear Medicine, Hippokratio Hospital, Thessaloniki, Greece.
Abstract
Renal involvement is very common in tuberous sclerosis complex (TSC) and is characterized by the development of angiomyolipoma and cysts. The aims of the present study were to assess kidney function and clinical features of renal involvement in TSC, including kidney function and blood pressure (BP) levels in children, adolescents and young adults. Non-selected patients with a definite diagnosis of TSC attending the paediatric neurology outpatient department of a tertiary hospital were included in a cross-sectional study. All participants had a renal imaging study within 6 months of ambulatory blood pressure (BP) and glomerular filtration rate (GFR) assessment. Data on demographics, history, genotype, kidney function at diagnosis and last imaging were collected. Twenty patients were enrolled in this study with a median age of 15 years (IQR range 9 to 18). About 23.5% of the participants had ambulatory hypertension. Systolic BP levels correlated significantly with GFRDTPA values despite the absence of hyperfiltration. Patients that developed hypertension and possibly those with angiomyolipoma or cysts had higher GFR levels in childhood and adolescence. All the patients with ambulatory hypertension had angiomyolipoma or cysts on renal imaging studies. CONCLUSIONS: Hypertension may present with increased frequency in young patients with kidney disease associated with TSC. Routine ambulatory BP measurement should be part of the annual clinical assessment in patients with TSC. WHAT IS KNOWN: • Nearly half of the patients with TSC have a premature decline in their renal function in their fifth decade of life. • Hypertension and hyperfiltration have been proposed as modifiable factors of progression of renal decline in patients with TSC-related renal disease. WHAT IS NEW: • Hypertension is prevalent in youth with tuberous sclerosis complex. • SBP levels have a positive relation with GFR levels within the normal range of GFRDTPA values.
Renal involvement is very common in tuberous sclerosis complex (TSC) and is characterized by the development of angiomyolipoma and cysts. The aims of the present study were to assess kidney function and clinical features of renal involvement in TSC, including kidney function and blood pressure (BP) levels in children, adolescents and young adults. Non-selected patients with a definite diagnosis of TSC attending the paediatric neurology outpatient department of a tertiary hospital were included in a cross-sectional study. All participants had a renal imaging study within 6 months of ambulatory blood pressure (BP) and glomerular filtration rate (GFR) assessment. Data on demographics, history, genotype, kidney function at diagnosis and last imaging were collected. Twenty patients were enrolled in this study with a median age of 15 years (IQR range 9 to 18). About 23.5% of the participants had ambulatory hypertension. Systolic BP levels correlated significantly with GFRDTPA values despite the absence of hyperfiltration. Patients that developed hypertension and possibly those with angiomyolipoma or cysts had higher GFR levels in childhood and adolescence. All the patients with ambulatory hypertension had angiomyolipoma or cysts on renal imaging studies. CONCLUSIONS: Hypertension may present with increased frequency in young patients with kidney disease associated with TSC. Routine ambulatory BP measurement should be part of the annual clinical assessment in patients with TSC. WHAT IS KNOWN: • Nearly half of the patients with TSC have a premature decline in their renal function in their fifth decade of life. • Hypertension and hyperfiltration have been proposed as modifiable factors of progression of renal decline in patients with TSC-related renal disease. WHAT IS NEW: • Hypertension is prevalent in youth with tuberous sclerosis complex. • SBP levels have a positive relation with GFR levels within the normal range of GFRDTPA values.
Authors: Peter Janssens; Karen Van Hoeve; Liesbeth De Waele; Stéphanie De Rechter; Kathleen J Claes; Els Van de Perre; Karl Martin Wissing; Bert Bammens; Anna Jansen; Djalila Mekahli Journal: Pediatr Nephrol Date: 2018-07-09 Impact factor: 3.714
Authors: M van Slegtenhorst; R de Hoogt; C Hermans; M Nellist; B Janssen; S Verhoef; D Lindhout; A van den Ouweland; D Halley; J Young; M Burley; S Jeremiah; K Woodward; J Nahmias; M Fox; R Ekong; J Osborne; J Wolfe; S Povey; R G Snell; J P Cheadle; A C Jones; M Tachataki; D Ravine; J R Sampson; M P Reeve; P Richardson; F Wilmer; C Munro; T L Hawkins; T Sepp; J B Ali; S Ward; A J Green; J R Yates; J Kwiatkowska; E P Henske; M P Short; J H Haines; S Jozwiak; D J Kwiatkowski Journal: Science Date: 1997-08-08 Impact factor: 47.728
Authors: P T Brook-Carter; B Peral; C J Ward; P Thompson; J Hughes; M M Maheshwar; M Nellist; V Gamble; P C Harris; J R Sampson Journal: Nat Genet Date: 1994-12 Impact factor: 38.330
Authors: Jason C Warncke; Katie E Brodie; Erin C Grantham; Salvatore P Catarinicchia; Suhong Tong; Kimi L Kondo; Nicholas G Cost Journal: J Urol Date: 2016-09-25 Impact factor: 7.450
Authors: J Chris Kingswood; John J Bissler; Klemens Budde; John Hulbert; Lisa Guay-Woodford; Julian R Sampson; Matthias Sauter; Jane Cox; Uday Patel; Frances Elmslie; Chris Anderson; Bernard A Zonnenberg Journal: Nephron Date: 2016-08-10 Impact factor: 2.847
Authors: R S Kandt; J L Haines; M Smith; H Northrup; R J Gardner; M P Short; K Dumars; E S Roach; S Steingold; S Wall Journal: Nat Genet Date: 1992-09 Impact factor: 38.330
Authors: Sam Amin; Andrew Lux; Nuala Calder; Matthew Laugharne; John Osborne; Finbar O'callaghan Journal: Dev Med Child Neurol Date: 2016-12-09 Impact factor: 5.449